Aim:

To study the regulatory effects of 9-cis retinoic acid (RA) on the expression of human homeobox gene NKX3.1 in prostate cancer cell line LNCaP.

Methods:

Flow cytometry, reverse transcriptase polymerase chain reaction and Western blotting were performed to evaluate the effects of 9-cis RA on NKX3.1 expression and cell cycle of LNCaP cells. To identify a regulatory region within the NKX3.1 promoter contributing to the regulation induced by 9-cis RA, we have constructed an NKX3.1 promoter-reporter plasmid, pGL₃-1040bp, and its 5'-deletion mutants, which were transfected into LNCaP cells with treatment of 9-cis RA in indicated concentrations.

Results:

With the treatment of 9-cis RA, the NKX3.1 promoter activity was increased in reporter gene assay and NKX3.1 expression was enhanced at both mRNA and protein levels in LNCaP cells. We found that the region between -936 and -921 in the upstream of NKX3.1 gene involved the inducible regulation by 9-cis RA treatment. In flow cytometry, 9-cis RA treatment caused accumulation of cells in the G₁ phase of the cell cycle and a fewer cells pass through to G₂/M.

Conclusion:

Our results demonstrated that 9-cis RA as a differentiating agent can arrest prostate cancer cells in G₁ phase and reduce cell mitosis, and upregulate the expression of human homeobox gene NKX3.1, which is thought to play an important role in prostate differentiation and to act as a tumor suppressor gene in the prostate.

References

1. Prescott JL, Blok L, Tindall DJ. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 1998; 35: 71–80. | Article | PubMed | ISI | ChemPort |
2. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, et al. Roles for Nkx3.1 in prostate development and cancer Genes Dev 1999; 13: 966–77. | Article | PubMed | ISI | ChemPort |
3. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis Cancer Res 2002; 62: 2999–3004. | PubMed | ISI | ChemPort |
4. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression Cancer Res 2000; 60: 6111–5. | PubMed | ISI | ChemPort |
5. He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer Genomics 1997; 43: 69–77. | Article | PubMed | ISI | ChemPort |
6. Swalwell JI, Vocke CD, Yang Y, Walker JR, Grouse L, Myers SH, et al. Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer. Genes Chromosomes Cancer 2002; 33: 201–5. | Article | PubMed | ChemPort |
7. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996; 56: 2411–6. | PubMed | ISI | ChemPort |
8. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, et al. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia Mol Cell Biol 2002; 22: 1495–503. | Article | PubMed | ISI | ChemPort |
9. Blutt SE, Allegretto EA, Pike JW, Weigel NL. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 1997; 138: 1491–7. | Article | PubMed | ISI | ChemPort |
10. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, et al. 9-cis-retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 1994; 54: 6549–56. | PubMed | ISI | ChemPort |
11. Gottardis MM, Lamph WW, Shalinsky DR, Wellstein A, Heyman RA. The efficacy of 9-cis-retinoic acid in experimental models of cancer. Breast Cancer Res Treat 1996; 38: 85–96. | Article | PubMed | ISI | ChemPort |
12. Lutzky J, Vujicic M, Yamanishi DT, Bhalla K. Antiproliferative effects of all-trans-retinoic acid (tRA) and 9-cis-retinoic acid (9-cisRA) on human lymphoid cell lines. Proc Am Assoc Cancer Res 1993; 34: 292.
13. Guzey M, Demirpence E, Criss W, DeLuca HF. Effects of retinoic acid (all-trans and 9-cis) on tumor progression in small-cell lung carcinoma. Biochem Biophys Res Commun 1998; 242: 369–75. | Article | PubMed | ChemPort |
14. Giannini F, Maestro R, Vukosavljevic T, Pomponi F, Boiocchi M. All-trans, 13-cis, and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int J Cancer 1997; 70: 194–200. | Article | PubMed | ISI | ChemPort |
15. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 1994; 54: 4614–7. | PubMed | ISI | ChemPort |
16. Anzano MA, Peer CW, Smith JM, Mullen LT, Shrader MW, Logsdon DL, et al. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. J Natl Cancer Inst 1996; 88: 123–5. | Article | PubMed | ChemPort |
17. Zheng Y, Kramer PM, Olson G, Lubet RA, Steele VE, Kelloff GJ, et al. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis 1997; 18: 2119–25. | Article | PubMed | ChemPort |
18. Jiang AL, Zhang JY, Young C, Hu XY, Wang YM, Liu ZF, et al. Molecular cloning and characterization of human homeobox gene NKX3.1 promoter Acta Biochim Biophys Sin 2004; 36: 64–7. | PubMed | ChemPort |
19. Jia WJ, Tong BY, Zhou GM, Li ZX, Zha XL, Ding Q, et al. Expression of NKX3.1 and Pten in prostate carcinoma tissue and the studies on effects of PC3 cell line after NKX3.1 transfection Fudan Univ J Med Sci 2004; 31: 551–5. | ChemPort |

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.